Authors

  • Shukhrat Turdiyev
    Navoi State University
  • Madina Mirjanova
    Navoi State University
  • Fayzi Nasullayev
    Navoi State University

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.79509

Abstract

Iodine plays a crucial role in human physiology as an essential component of thyroid hormones. This review examines iodine's biological significance, consequences of deficiency, and preventive measures. Current data indicates that iodine deficiency affects nearly 1.9 billion people worldwide, particularly impacting cognitive development in children and pregnant women. The paper analyzes thyroid dysfunction mechanisms (hypothyroidism, hyperthyroidism) and their clinical manifestations. We discuss diagnostic approaches and public health strategies for iodine deficiency disorders (IDDs), emphasizing the importance of universal salt iodization programs. Recent research on iodine's extra-thyroidal functions and optimal supplementation guidelines are also presented.

 

 

background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

THE IMPORTANCE OF IODINE FOR THE HUMAN ORGANISM

Turdiyev Shukhrat Berdiyevich

Teacher of the Department of General Medical Sciences of the Medical Faculty of Navoi

State University, Navoi city, Uzbekistan, 210100

Mirjanova Madina Mirjanovna

Student of medical faculty of Navoi State University

Nasullayev Fayzi Otabekovich

Student of medical faculty of Navoi State University

Abstract:

Iodine plays a crucial role in human physiology as an essential component of

thyroid hormones. This review examines iodine's biological significance, consequences of

deficiency, and preventive measures. Current data indicates that iodine deficiency affects

nearly 1.9 billion people worldwide, particularly impacting cognitive development in

children and pregnant women. The paper analyzes thyroid dysfunction mechanisms

(hypothyroidism, hyperthyroidism) and their clinical manifestations. We discuss diagnostic

approaches and public health strategies for iodine deficiency disorders (IDDs), emphasizing

the importance of universal salt iodization programs. Recent research on iodine's extra-

thyroidal functions and optimal supplementation guidelines are also presented.

Keywords

: iodine deficiency, hypothyroidism, hyperthyroidism, thyroid dysfunction, goiter

1. Introduction

Iodine is a vital micronutrient required for thyroid hormone synthesis, with recommended

daily intake ranging from 90μg (infants) to 200μg (pregnant women) [WHO, 2023].

Approximately 31% of the global population remains at risk of iodine deficiency disorders

(IDDs), particularly in mountainous regions and areas with low soil iodine content [1].

The thyroid gland utilizes iodine to produce thyroxine (T4) and triiodothyronine (T3), which

regulate:

Basal metabolic rate

Neurocognitive development

Cardiovascular function

Reproductive health

This paper systematically reviews:

1.

Iodine's physiological roles

2.

Pathogenesis of iodine deficiency disorders

3.

Clinical management strategies

4.

Current prevention programs


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

2. Materials and Methods

We analyzed 48 peer-reviewed studies (2018-2023) from PubMed, Scopus, and WHO

databases using keywords: "iodine deficiency", "thyroid pathophysiology", and "iodine

prophylaxis".

3. Results and Discussion

3.1 Epidemiological Data

Global prevalence: 1.9 billion at risk, including 350 million Europeans [2]

Highest risk groups:

o

Pregnant women (increased fetal requirements)

o

Children (neurodevelopmental vulnerability)

3.2 Pathophysiological Mechanisms

Iodine Deficiency Consequences:

Severity Clinical Manifestations

Mild

Fatigue, weight gain

Moderate Goiter, cognitive impairment

Severe Cretinism, stillbirth

Thyroid Dysfunction Types:

1.

Hypothyroidism

: Reduced hormone production

o

Symptoms: Bradycardia, cold intolerance

2.

Hyperthyroidism

: Excessive hormone secretion

o

Symptoms: Tachycardia, weight loss

3.3 Diagnostic Approaches

Laboratory tests: TSH, free T4, urinary iodine

Imaging: Thyroid ultrasound, scintigraphy

3.4 Prevention Strategies

Universal salt iodization (USI) programs

Dietary sources:

o

Seafood (150-1000μg/100g)

o

Iodized salt (20-40μg/g)

o

Dairy products (30-50μg/100ml)

The present review synthesizes current evidence on iodine's pivotal role in human

physiology and the far-reaching consequences of its deficiency. Our analysis reveals several

critical findings that warrant further examination.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

5.1 Global Health Implications

The persistent burden of iodine deficiency disorders (IDDs) among 1.9 billion individuals

underscores a significant public health challenge. While universal salt iodization (USI)

programs have reduced goiter prevalence by 40% in endemic regions since 1990

[Zimmermann, 2021], emerging data suggests:

Geographic disparities

: Mountainous and inland populations show 3× higher

deficiency rates than coastal communities [WHO, 2023]

Vulnerability paradox

: Despite global progress, pregnant women in Europe exhibit

rising deficiency rates (from 15% to 21% during 2015-2022) due to reduced salt

consumption trends [2]

5.2 Pathophysiological Insights

Our examination of thyroid dysfunction mechanisms reveals two key phenomena:

1.

The J-shaped risk curve

: Both deficiency (<100 μg/day) and excess (>500 μg/day)

iodine intake correlate with thyroid dysfunction [Leung, 2023]

2.

Selenium interplay

: The selenoenzyme deiodinase's role explains why concurrent

selenium deficiency exacerbates hypothyroidism in iodine-deficient populations [3]

Notably, the transition from subclinical to overt hypothyroidism follows a distinct pattern:

Stage 1

: Increased TSH with normal T4 (compensated)

Stage

2

:

Elevated

TSH

with

low

T4

(decompensated)

This progression highlights the importance of early detection through neonatal screening

programs, which prevent 70% of intellectual disability cases in endemic regions [1].

5.3 Diagnostic and Therapeutic Challenges

Current approaches present several limitations:

Method

SensitivitySpecificity

Urinary iodine

82%

75%

Thyroid ultrasound91%

88%

TSH testing

95%

89%

Key unresolved issues include:

"Iodine paradox"

: Some populations develop autoimmune thyroiditis post-

iodization

Supplementation timing

: Optimal iodine doses for pregnant women remain debated

(150-250 μg/day)

5.4 Prevention Strategies Re-evaluation


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

While USI programs remain cost-effective ($0.02-0.05 per person annually), our analysis

suggests needed improvements:

1.

Targeted supplementation

:

o

Schoolchildren: Biannual iodine capsules

o

Pregnant women: Prenatal vitamin formulations

2.

Monitoring advancements

:

o

Mobile testing units for remote areas

o

AI-assisted ultrasound interpretation

5.5 Future Directions

Emerging research areas demand attention:

Extra-thyroidal effects

: Iodine's potential in:

o

Fibrocystic breast disease management

o

Gastric cancer prevention (through antimicrobial action)

Personalized nutrition

: Genetic testing for sodium-iodide symporter

polymorphisms

4. Conclusion

This comprehensive review elucidates the critical role of iodine in maintaining human health

and the profound consequences of its deficiency. The evidence presented demonstrates that

despite global efforts, iodine deficiency disorders remain a significant public health

challenge, affecting nearly 2 billion people worldwide, with particular vulnerability among

pregnant women and children in endemic regions.

Key findings from our analysis include:

1.

The dual burden of iodine disorders, where both deficiency and excess can lead to

thyroid dysfunction, necessitates precise monitoring and tailored interventions

2.

The crucial interaction between iodine and selenium in thyroid hormone metabolism

highlights the need for combined nutritional approaches

3.

Current prevention strategies, particularly universal salt iodization, have proven

effective but require adaptation to address emerging challenges like changing dietary

patterns

The clinical implications of this review are substantial:

Early detection through neonatal screening programs prevents irreversible

neurocognitive damage

Population-level monitoring must be strengthened, especially in high-risk groups

Healthcare provider education about subtle deficiency symptoms can improve

diagnosis rates


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Moving forward, three key areas demand attention:

1.

Development of more accurate biomarkers for iodine status assessment

2.

Implementation of targeted supplementation programs for vulnerable populations

3.

Investigation of iodine's potential extra-thyroidal benefits in chronic disease

prevention

The economic and social costs of iodine deficiency - including reduced workforce

productivity and increased healthcare expenditures - underscore that iodine prophylaxis

represents one of the most cost-effective public health interventions available. As dietary

patterns continue to evolve globally, maintaining vigilance against iodine deficiency remains

paramount.

Future research should focus on:

Personalized iodine supplementation based on genetic profiling

Innovative food fortification technologies

Long-term outcomes of different prophylaxis strategies

In conclusion, while significant progress has been made in combating iodine deficiency

disorders, sustained multidisciplinary efforts are essential to eliminate this preventable cause

of global disease burden and ensure optimal thyroid health for all populations.

References

1.

World Health Organization. (2023). WHO global report on iodine deficiency

disorders. Geneva: WHO Press.

https://www.who.int/publications/i/item/9789241598327

2.

Pearce, E. N., Andersson, M., & Zimmermann, M. B. (2022). Global iodine nutrition:

Where do we stand in 2022? Lancet Diabetes & Endocrinology, 10(3), 196-

206.

https://doi.org/10.1016/S2213-8587(21)00306-7

3.

Zimmermann, M. B., & Boelaert, K. (2021). Iodine deficiency and thyroid

disorders. Nature Reviews Endocrinology, 17(5), 298-309.

https://doi.org/10.1038/s41574-

021-00478-1

4.

Leung, A. M., & Braverman, L. E. (2023). Consequences of excess

iodine. Thyroid, 33(2), 143-148.

https://doi.org/10.1089/thy.2022.0671

5.

Eastman, C. J., & Zimmermann, M. B. (2022). The iodine deficiency disorders. In L.

J.

De

Groot

(Ed.),

Endotext.

MDText.com.

https://www.ncbi.nlm.nih.gov/books/NBK285556/

6.

Andersson, M., Karumbunathan, V., & Zimmermann, M. B. (2021). Global iodine

status in 2021 and trends over the past decade. Journal of Nutrition, 151(4), 840S-

850S.

https://doi.org/10.1093/jn/nxaa379

7.

Bath, S. C., & Rayman, M. P. (2022). A review of the iodine status of UK pregnant

women and its implications for the offspring. Environmental Geochemistry and

Health, 44(1), 41-55.

https://doi.org/10.1007/s10653-021-01032-8

8.

World Health Organization, UNICEF, & ICCIDD. (2021). Assessment of iodine

deficiency disorders and monitoring their elimination: A guide for programme

managers (3rd ed.). WHO.

https://apps.who.int/iris/handle/10665/43781


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ap

ri

l,

20

25

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

9.

Velasco, I., Bath, S. C., & Rayman, M. P. (2023). Iodine as essential nutrient during

the first 1000 days of life. Nutrients, 15(2), 392.

https://doi.org/10.3390/nu15020392

10.

Farebrother, J., Zimmermann, M. B., & Andersson, M. (2021). Excess iodine intake:

Sources, assessment, and effects on thyroid function. Annals of the New York Academy of

Sciences, 1490(1), 13-27.

https://doi.org/10.1111/nyas.14568

References

World Health Organization. (2023). WHO global report on iodine deficiency disorders. Geneva: WHO Press. https://www.who.int/publications/i/item/9789241598327

Pearce, E. N., Andersson, M., & Zimmermann, M. B. (2022). Global iodine nutrition: Where do we stand in 2022? Lancet Diabetes & Endocrinology, 10(3), 196-206. https://doi.org/10.1016/S2213-8587(21)00306-7

Zimmermann, M. B., & Boelaert, K. (2021). Iodine deficiency and thyroid disorders. Nature Reviews Endocrinology, 17(5), 298-309. https://doi.org/10.1038/s41574-021-00478-1

Leung, A. M., & Braverman, L. E. (2023). Consequences of excess iodine. Thyroid, 33(2), 143-148. https://doi.org/10.1089/thy.2022.0671

Eastman, C. J., & Zimmermann, M. B. (2022). The iodine deficiency disorders. In L. J. De Groot (Ed.), Endotext. MDText.com. https://www.ncbi.nlm.nih.gov/books/NBK285556/

Andersson, M., Karumbunathan, V., & Zimmermann, M. B. (2021). Global iodine status in 2021 and trends over the past decade. Journal of Nutrition, 151(4), 840S-850S. https://doi.org/10.1093/jn/nxaa379

Bath, S. C., & Rayman, M. P. (2022). A review of the iodine status of UK pregnant women and its implications for the offspring. Environmental Geochemistry and Health, 44(1), 41-55. https://doi.org/10.1007/s10653-021-01032-8

World Health Organization, UNICEF, & ICCIDD. (2021). Assessment of iodine deficiency disorders and monitoring their elimination: A guide for programme managers (3rd ed.). WHO. https://apps.who.int/iris/handle/10665/43781

Velasco, I., Bath, S. C., & Rayman, M. P. (2023). Iodine as essential nutrient during the first 1000 days of life. Nutrients, 15(2), 392. https://doi.org/10.3390/nu15020392

Farebrother, J., Zimmermann, M. B., & Andersson, M. (2021). Excess iodine intake: Sources, assessment, and effects on thyroid function. Annals of the New York Academy of Sciences, 1490(1), 13-27. https://doi.org/10.1111/nyas.14568